Skip to main content
. Author manuscript; available in PMC: 2012 Aug 15.
Published in final edited form as: Cancer Res. 2011 Jul 1;71(16):5512–5521. doi: 10.1158/0008-5472.CAN-10-2614

Figure 3.

Figure 3

KDR copy number gain (CNG) associated with outcome in NSCLC patients treated with adjuvant chemotherapy. Kaplan-Meier curve for overall survival (OS) and recurrence-free survival (RFS) by KDR CNG in NSCLC patients and two subgroups of platinum adjuvant therapy and without adjuvant therapy (E, event; N, total number of cases).